Fixing drug discovery’s most persistent problem with AI
Drug Target Review
JULY 10, 2025
Absorption, distribution, metabolism, excretion and toxicity – collectively known as ADMET – are among the most critical and challenging hurdles in small molecule drug discovery. For example, the platform may predict a 75 percent likelihood that a molecule will face metabolic stability issues.
Let's personalize your content